Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

143.41 +0.03 (+0.02%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

20 21 22 23 24 25 26 27 Next >

Insulet Corporation (PODD) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

PODD earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Insulet Posts Mixed Third Quarter, But Raises Sales Guide On Narrow Beat ↗

November 04, 2021

Insulet raised its full-year sales outlook Thursday on its third-quarter sales beat.

Via Investor's Business Daily

Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year

November 04, 2021

From Insulet Corporation

Via Business Wire

Insulet Honors Diabetes Awareness with Global Activities and Events

November 01, 2021

From Insulet Corporation

Via Business Wire

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

October 18, 2021

From Insulet Corporation

Via Business Wire

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Insulet's Insulin Delivery System Shows Durable Glycemic Control With One Year of Use ↗

September 30, 2021

Insulet Corporation (NASDAQ: PODD) presented data from the pivotal trial extension phase of the Omnipod 5 Automated Insulin Delivery System. Omnipod 5 is a...

Via Benzinga

Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use

September 30, 2021

From Insulet Corporation

Via Business Wire

Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021

September 29, 2021

From Insulet Corporation

Via Business Wire

5 Top Stocks for September ↗

September 11, 2021

Our analysts give you five picks you can add to your portfolio today.

Via The Motley Fool

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

Insulet to Present at Upcoming Investor Conferences

August 26, 2021

From Insulet Corporation

Via Business Wire

Looking into Insulet's Return on Capital Employed ↗

August 23, 2021

After pulling data from Benzinga Pro it seems like during Q2, Insulet (NASDAQ:PODD) earned $26.30 million, a 61.35% increase from the preceding quarter. Insulet also posted a...

Via Benzinga

FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps ↗

August 16, 2021

The

Via Benzinga

Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States

August 16, 2021

From Insulet Corporation

Via Business Wire

Insulet Introduces Omnipod DASH® System at Australasian Diabetes Congress

August 11, 2021

From Insulet Corporation

Via Business Wire

Insulet Stock Dives On Unexpected Delay For Next-Generation Insulin Pump ↗

August 06, 2021

Insulet said Thursday it expects a one-quarter delay for its next-generation insulin pump, leading PODD stock to tumble on Friday.

Via Investor's Business Daily

Insulet Corporation (PODD) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

PODD earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Insulet Reports Second Quarter 2021 Revenue Increase of 16% Year-Over-Year

August 05, 2021

From Insulet Corporation

Via Business Wire

3 Stocks to Buy That Should Get a Boost From Pandemic-Driven Consumer Weight Gain ↗

July 31, 2021

Athletic-apparel maker Lululemon and two diabetes specialists are poised to get a long-term tailwind from the COVID-19 pandemic.

Via The Motley Fool

Insulet to Present at Upcoming Investor Conferences

July 26, 2021

From Insulet Corporation

Via Business Wire

Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021

July 01, 2021

From Insulet Corporation

Via Business Wire

Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years

June 26, 2021

From Insulet Corporation

Via Business Wire

Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System

June 24, 2021

From Insulet Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗

May 25, 2021

Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...

Via Benzinga

Insulet Corp (PODD) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

PODD earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year

May 06, 2021

From Insulet Corporation

Via Business Wire

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2

...

20 21 22 23 24 25 26 27 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Insulet Corporation - Common Stock (NQ:PODD)

All News about Insulet Corporation - Common Stock